コンテンツにジャンプ

トップページ > 各部紹介 > データサイエンス研究部 > 業績論文 > 2017年

2017年

英文

  1. Katanoda KHori M. Incidence rate for gallbladder cancer in Japanese in Japan and in the United States from the Cancer Incidence in FiveContinents. Jpn J Clin Oncol, 2017 Feb 9;47(2):187-188. [PubMed]
  2. Katanoda K, Shibata A, Matsuda T, Hori M, Nakata K, Narita Y, Ogawa C, Munakata W, Kawai A, Nishimoto H. Childhood, adolescent and young adult cancer incidence in Japan in 2009-2011. Jpn J Clin Oncol, 2017 Aug 1;47(8):762-771. [PubMed]
  3. Katanoda K, Noda M, Goto A, Mizunuma H, Lee JS, Hayashi K. Impact of birth weight on adult-onset diabetes mellitus in relation to current body mass index: The Japan Nurses' Health Study. J Epidemiol, 2017 Sep;27(9):428-434. [PubMed]
  4. Hori MKatanoda K. Incidence rate for melanoma of skin cancer in Japanese in Japan and in the United States from the Cancer Incidence in Five Continents. Jpn J Clin Oncol, 2017 Apr 1;47(4):373-374. [PubMed]
  5. Katanoda KHori M. The estimates of 5-year lung cancer prevalence in adult population in 2012. Jpn J Clin Oncol, 2017 Sep 1;47(9):896-897. [PubMed]
  6. Hori MKatanoda K. The estimates of 5-year breast cancer prevalence in adult population in 2012. Jpn J Clin Oncol, 2017 Oct 1;47(10):993-994. [PubMed]
  7. Sado J, Kitamura T, Kitamura Y, Sobue T, Nishino Y, Tanaka H, Nakayama T, Tsuji I, Ito H, Suzuki T, Katanoda K, Tominaga S. Association between coffee consumption and all-sites cancer incidence and mortality. Cancer Sci, 2017 Oct;108(10):2079-2087. [PubMed]
  8. Shinagawa T, Kitamura T, Katanoda K, Matsuda T, Ito Y, Sobue T. The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: A descriptive study. Int J Cancer, 2017 Feb 1;140(3):618-625. [PubMed]
  9. Sado J, Kitamura T, Kitamura Y, Zha L, Liu R, Sobue T, Nishino Y, Tanaka H, Nakayama T, Tsuji I, Ito H, Suzuki T, Katanoda K, Tominaga S. Rationale, design, and profile of the Three-Prefecture Cohort in Japan: A 15-year follow-up. J Epidemiol, 2017 Apr;27(4):193-199. [PubMed]
  10. Chen Y, Wu F, Saito E, Lin Y, Song M, Luu HN, Gupta PC, Sawada N, Tamakoshi A, Shu XO, Koh WP, Xiang YB, Tomata Y, Sugiyama K, ParkSK, Matsuo K, Nagata C, Sugawara Y, Qiao YL, You SL, Wang R, Shin MH, Pan WH, Pednekar MS, Tsugane S, Cai H, Yuan JM, Gao YT, Tsuji I,Kanemura S, Ito H, Wada K, Ahn YO, Yoo KY, Ahsan H, Chia KS, Boff etta P, Zheng W, Inoue M, Kang D, Potter JD. Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium. Diabetologia, 2017 Jun;60(6):1022-1032. [PubMed]
  11. Narita S, Inoue M, Saito E, Abe SK, Sawada N, Ishihara J, Iwasaki M, Yamaji T, Shimazu T, Sasazuki S, Shibuya K, Tsugane S. Dietary fiber intake and risk of breast cancer defined by estrogen and progesterone receptor status: the Japan Public Health Center-based Prospective Study. Cancer Causes Control, 2017 Jun;28(6):569-578. [PubMed]
  12. Teng Y, Saito E, Abe SK, Sawada N, Iwasaki M, Yamaji T, Shimazu T, Sasazuki S, Inoue M, Tsugane S. Female reproductive factors,exogenous hormone use, and pancreatic cancer risk: the Japan Public Health Center-based prospective study. Eur J Cancer Prev, 2017 Sep;26(5):378-384. [PubMed]
  13. Nomura S, Sakamoto H, Glenn S, Tsugawa Y, Abe SK, Rahman MM, Brown JC, Ezoe S, Fitzmaurice C, Inokuchi T, Kassebaum NJ, KawakamiN, Kita Y, Kondo N, Lim SS, Maruyama S, Miyata H, Mooney MD, Naghavi M, Onoda T, Ota E, Otake Y, Roth GA, Saito E, Tabuchi T, TakasakiY, Tanimura T, Uechi M, Vos T, Wang H, Inoue M, Murray CJL, Shibuya K. Population health and regional variations of disease burden inJapan, 1990-2015: a systematic subnational analysis for the Global Burden of Disease Study 2015. Lancet, 2017 Sep 23;390(10101):1521-1538. [PubMed]
  14. Song H, Saito E, Sawada N, Abe SK, Hidaka A, Shimazu T, Yamaji T, Goto A, Iwasaki M, Sasazuki S, Ye W, Inoue M, Tsugane S. Body massindex change during adulthood and risk of oesophageal squamous-cell carcinoma in a Japanese population: the Japan Public Health (JPHC)-based prospective study. Br J Cancer, 2017 Nov 21;117(11):1715-1722. [PubMed]
  15. Taniyama Y, Katanoda K, Charvat H, Hori M, Ohno Y, Sasazuki S, Tsugane S. Estimation of lifetime cumulative incidence and mortality risk ofgastric cancer. Jpn J Clin Oncol, 2017 Nov 1;47(11):1097-1102. [PubMed]
  16. Song H, Saito E, Sawada N, Abe SK, Hidaka A, Shimazu T, Yamaji T, Goto A, Iwasaki M, Sasazuki S, Ye W, Inoue M, Tsugane S. Perceivedstress level and risk of cancer incidence in a Japanese population: the Japan Public Health Center (JPHC)-based Prospective Study. Sci Rep, 2017 11;7(1):12964. [PubMed]
  17. Saito E, Inoue M, Tsugane S, Ito H, Matsuo K, Wakai K, Wada K, Nagata C, Tamakoshi A, Sugawara Y, Tsuji I, Mizoue T, Tanaka K, SasazukiS. Smoking cessation and subsequent risk of cancer: A pooled analysis of eight population-based cohort studies in Japan. Cancer Epidemiol, 2017 Dec;51:98-108. [PubMed]

和文

  1. 片野田 耕太. 【がんの予防は可能か】 罹患・死亡統計からみたがんの予防可能性. 医学のあゆみ, 261:851-855, 2017
  2. 井上 真奈美, 齋藤 英子. 【がん転移学(上)-がん転移のメカニズムと治療戦略:その基礎と臨床-】 がんの疫学 アジアコホートコンソーシアム研究からみた生活習慣とがんリスク. 日本臨床, 75:91-96, 2017
  3. 片野田 耕太. 受動喫煙ってなんですか? 保健体育教室, 304 17-21, 2017
  4. 片野田 耕太. 喫煙による健康影響. 化学物質と環境, 142:6-8, 2017
  5. 片野田 耕太. 喫煙の健康影響とたばこ対策 第1回たばこ製品の現状. 中学保健ニュース, 4-5,12, 2017
  6. 片野田 耕太. 喫煙の健康影響とたばこ対策 第2回 たばこの健康影響. 中学保健ニュース, 4-5,12, 2017
  7. 片野田 耕太. 喫煙の健康影響とたばこ対策 第3回 たばこ対策. 中学保健ニュース, 4-5,12, 2017